Disease | lung disease |
Phenotype | C0011644|scleroderma |
Sentences | 9 |
PubMedID- 21314931 | The aim of the study was to investigate the presence of thymosins beta4, beta4 sulfoxide, and beta10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. |
PubMedID- 25110305 | Good outcome of interstitial lung disease in patients with scleroderma associated to anti-pm/scl antibody. |
PubMedID- 22723597 | Up-regulated expression of hla-drb5 transcripts and high frequency of the hla-drb5*01:05 allele in scleroderma patients with interstitial lung disease. |
PubMedID- 21552414 | Background: scleroderma (ssc) patients with active interstitial lung disease (ild) experience a decline in lung function and increased mortality; cyclophosphamide (cyc) therapy may stabilize lung function at one and two years follow-up. |
PubMedID- 22826062 | Interstitial lung disease often coexists with scleroderma and is accompanied by functional lung abnormalities. |
PubMedID- 20352228 | To evaluate the role and the prognostic value of bronchoalveolar lavage (bal) in scleroderma patients with interstitial lung disease. |
PubMedID- 22402140 | This study aimed to evaluate vegf concentration in the bronchoalveolar lavage fluid (balf) of scleroderma patients with interstitial lung disease, to correlate the cytokine levels in plasma and in the lung with pulmonary functional, radiological and cellular parameters, and with the progression of lung disease. |
PubMedID- 23092273 | Indeed pulmonary hypertension secondary to scleroderma or other types of inflammatory lung disease has a far worse prognosis and appears to impact the rv more profoundly than more conventional types of pulmonary hypertension. |
PubMedID- 24627847 | A case of sine scleroderma with parenchymal lung disease. |
Page: 1